We serve S-(4,4,5,5,5-Pentafluoropentyl)isothiourea Methanesulfonate CAS:1107606-68-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:S-(4,4,5,5,5-Pentafluoropentyl)isothiourea Methanesulfonate
CAS.NO:1107606-68-7
Synonyms:S-(4,4,5,5,5-Pentafluoropentyl)isothiourea Methanesulfonate
4,4,5,5,5-Pentafluoropentyl carbamimidothioate methanesulfonate
Molecular Formula:C7H13F5N2O3S2
Molecular Weight:332.31200
Specification:
For the treatment of metastatic breast cancer treatment drug Fulvestrant.
4,4,5,5,5-Pentafluoro-1-pentanol is reacted with p-Toluenesulfonic acid to obtain pentafluoropentanol p-toluenesulfonate, pentafluoropentanol p-toluenesulfonate is reacted with thiourea in ethanol to obtain product.
Contact us for information like S-(4,4,5,5,5-Pentafluoropentyl)isothiourea Methanesulfonate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4,4,5,5,5-Pentafluoropentyl carbamimidothioate methanesulfonate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4,4,5,5,5-Pentafluoropentyl carbamimidothioate methanesulfonate Use and application,4,4,5,5,5-Pentafluoropentyl carbamimidothioate methanesulfonate technical grade,usp/ep/jp grade.
Related News: Multinational drugmakers usually cut the price of drugs when they go off-patent and face competition from generic versions, but such price drops were slow to happen in China, partially because many local drugmakers were unable to develop high-quality generic drugs to compete with off-patent branded drugs.1-Bromo-5-isopropoxy-2-methyl-4-nitrobenzene manufacturer But now, the metropolis of 11 million in Hubei province has become the face of a deadly coronavirus outbreak — a stigma the people of Wuhan increasingly find themselves unable to shake off.2,2'-(5-bromo-1,3-phenylene)dipyridine supplier Onconova Therapeutics, Inc. and Inceptua Medicines Access (a business unit of the Inceptua Group) recently announced they have entered into a collaboration to make available intravenous rigosertib via a Pre-approval Access Program in selected countries around the world.1-Bromo-2-chloroethane vendor In terms of business, the industrial business increased by 7.97% year-on-year, while the revenue from the trading business shrank to a certain extent. The growth rate of industrial business was significantly slower than 24% in the first half of the year, showing that the growth rate of industrial business was lower in the third quarter, which was also the main reason for the decline in the company’s operating income in the third quarter. The company’s industrial business is mainly pesticide intermediates, accounting for about 85%. The scale of the pesticide intermediate business is large and the base is high, which is putting pressure on growth.The Company’s immuno-oncology product candidates include natural killer (NK) cell and T-cell cancer immunotherapies, which are designed to synergize with well-established cancer therapies, including immune checkpoint inhibitors and monoclonal antibodies, and to target tumor-associated antigens with chimeric antigen receptors (CARs).
